About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Frequency of Cancer Recurrence in Cancer Survivors

by Julia Samuel on November 24, 2017 at 2:00 PM
Font : A-A+

Frequency of Cancer Recurrence in Cancer Survivors

A prior cancer history was common in a quarter of adults 65 or older and 11 percent of younger patients diagnosed with cancer from 2009 to 2013.

Why The Research Is Interesting: The number of cancer survivors in the United States is growing and is estimated to reach 26 million by 2040. Understanding how common a subsequent cancer is among patients with a history of cancer is important for understanding ongoing or new cancer risk in survivors.

Advertisement


Who and When: 740,990 people diagnosed with new cancer from 2009 through 2013.

What (Study Measures): Prior cancer among people diagnosed with a new cancer.

How (Study Design): This is an observational study. Because researchers are not intervening for purposes of the study they cannot control natural differences that could explain study findings.
Advertisement

Results: The frequency of prior cancer among patients diagnosed with new cancer ranged from 3.5 percent to 36.9 percent and most prior cancers were diagnosed in a different cancer site.

 Patients diagnosed with new cancer who have a history of cancer may be excluded from clinical trials and underrepresented in research. Understanding the impact of prior cancer is important to improve research, disease outcomes and patient experience.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Cervical Cancer Awareness Month 2022
Ultra-Low-Fat Diet
Goji Berries May Protect Against Age-Related Vision Loss
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Common Lifestyle Habits that Cause Diseases Health Benefits of Dandelion Plant Immune Checkpoint Inhibitors for Cancer Treatment Non-Communicable Diseases 

Recommended Reading
Breast Cancer Management: Advances
The crab that invades the breast is no more a fear factor with all the advancements that medical ......
Childhood Cancer
Childhood or pediatric cancers occur in children less than 15 years of age. They are rare and ......
Salivary Gland Cancer
Most salivary gland tumors are benign and occur in parotid gland. The most common sign of a ......
Prostate Specific Antigen [PSA]
PSA blood test is specific to prostate gland but not necessarily a cancer specific test but is ......
Common Lifestyle Habits that Cause Diseases
Cigarette smoking, unhealthy diets, overuse of alcohol, and physical inactivity are some of the most...
Health Benefits of Dandelion Plant
What is dandelion? Dandelion greens are nutrition powerhouses with a wide range of health benefits. ...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...
Non-Communicable Diseases
Non-Communicable Diseases (NCDs) are a group of chronic non-infectious diseases which include Cardio...
Tattoos A Body Art
Tattoos are a rage among college students who sport it for the ‘cool dude’ or ‘cool babe’ look...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
ASK A DOCTOR ONLINE
I have read and I do accept terms of use - Telemedicine

Advantage Medindia: FREE subscription for 'Personalised Health & Wellness website with consultation' (Value Rs.300/-)